Indocyanine Green (Intravitreal Chromovitrectomy)
Brand names: IC-Green
Indocyanine green is a tricarbocyanine dye used in ophthalmology as a vital stain to highlight the internal limiting membrane during chromovitrectomy and macular surgery, and as an angiographic agent.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
The dye selectively binds to and stains the internal limiting membrane, improving its visualisation and facilitating safe, complete membrane peeling during vitreoretinal surgery.
Prescribing in practice
- Indocyanine green contains iodide and is contraindicated in patients with iodine hypersensitivity, and retinal toxicity has been reported, so it must be used at the lowest effective concentration with minimal retinal exposure time.
- It must be reconstituted and used strictly according to the product information and only by clinicians trained in intraocular dye-assisted surgery.
- Limit light exposure and irrigation contact time on the retina to reduce the potential for phototoxic or direct retinal injury.
Monitoring
Intraoperative use is monitored by the surgical team with postoperative assessment of visual function and retinal integrity for any signs of toxicity.
Counselling the patient
- Inform the surgical team and patient that a coloured surgical dye is being used to aid membrane visualisation.
- Report any unexpected postoperative visual deterioration promptly for ophthalmic review.
Evidence & guidelines
Concerns about indocyanine green retinal toxicity have driven use of the lowest effective concentration and shortest retinal contact time in vitreoretinal surgical practice.
Reference: RCOphth ICG Angiography Guidelines; Haritoglou et al. Retina Review (ICG Toxicity); SPC IC-Green; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Revised Cardiac Risk Index (RCRI / Lee Index) · Perioperative Risk
- Revised Cardiac Risk Index (RCRI) · Pre-operative Risk
- EuroSCORE II · Prognosis
- TIMI Risk Score for UA/NSTEMI · ACS
- Gupta Perioperative Risk for MI or Cardiac Arrest (MICA) · Perioperative Risk
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme